Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9315459 | Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine | Benny Bang-Andersen, Andre Faldt, Silke Miller, Heidi Lopez de Diego | 2016-04-19 |
| 9125908 | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Benny Bang-Andersen, Arne Mork, Andre Faldt, Rene Holm, Heidi Lopez de Diego | 2015-09-08 |
| 9125909 | 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Benny Bang-Andersen, Andre Faldt, Arne Mork, Heidi Lopez de Diego, Rene Holm | 2015-09-08 |
| 9125910 | 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Benny Bang-Andersen, Arne Mork, Andre Faldt | 2015-09-08 |
| 8722684 | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Benny Bang-Andersen, Andre Faldt, Arne Mork, Heidi Lopez de Diego, Rene Holm +1 more | 2014-05-13 |
| 8664225 | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition | Nicholas Moore | 2014-03-04 |
| 8299095 | Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition and uses thereof | Benny Bang-Andersen, Andre Faldt, Silke Miller, Heidi Lopez de Diego | 2012-10-30 |
| 7732463 | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors | Ask Puschl, Benny Bang-Andersen, Morten Jorgensen, Thomas Ruhland | 2010-06-08 |